Ishita Drugs & Industries Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 3.32 | 3.09 | 4.60 |
| Operating Expense | 3.04 | 2.85 | 4.20 |
| Net Profit | 0.19 | 0.15 | 0.28 |
| Net Profit Margin | 5.72 | 4.85 | 6.09 |
| Earning Per Share | 0.65 | 0.49 | 0.94 |
| EBIDTA | 0.28 | 0.24 | 0.40 |
| Effective Tax Rate | 20.69 | 21.74 | 22.50 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 3.32 |
| Operating Expense | 3.04 |
| Net Profit | 0.19 |
| Net Profit Margin | 5.72 |
| Earning Per Share | 0.65 |
| EBIDTA | 0.28 |
| Effective Tax Rate | 20.69 |
Invest in Ishita Drugs & Industries Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 15.19 | 12.07 | 14.09 |
| Operating Expenses Annual | 14.28 | 11.31 | 13.00 |
| Operating Profit Annual | 1.19 | 0.96 | 1.20 |
| Interest Annual | 0.09 | 0.05 | 0.02 |
| Depreciation | 0.11 | 0.13 | 0.13 |
| Net Profit Annual | 0.75 | 0.58 | 0.80 |
| Tax Annual | 0.24 | 0.20 | 0.24 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 15.19 |
| Operating Expenses Annual | 14.28 |
| Operating Profit Annual | 1.19 |
| Interest Annual | 0.09 |
| Depreciation | 0.11 |
| Net Profit Annual | 0.75 |
| Tax Annual | 0.24 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 3.43 | 4.68 | 2.54 |
| Cash Flow from Operations | 2.12 | -2.90 | 3.08 |
| Cash Flow from Investing | 0.13 | 0.59 | -0.93 |
| Cash Flow from Financing | -0.87 | 1.05 | TBA |
| Cash Flow at the End | 4.81 | 3.43 | 4.68 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 3.43 |
| Cash Flow from Operations | 2.12 |
| Cash Flow from Investing | 0.13 |
| Cash Flow from Financing | -0.87 |
| Cash Flow at the End | 4.81 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 7.83 | 7.95 | 8.45 |
| PBIT Margin (%) | 7.11 | 6.88 | 7.52 |
| PBT Margin (%) | -71.89 | -130.65 | -368.63 |
| Net PROFIT Margin (%) | 4.94 | 4.81 | 5.68 |
| Return On Networth / Equity (%) | 7.86 | 6.53 | 9.76 |
| Return On Networth /Employed (%) | 10.77 | 8.86 | 12.90 |
| Return On Assets (%) | 7.50 | 6.20 | 9.77 |
| Total Debt / Equity (X) | 0.05 | 0.05 | TBA |
| Asset Turnover Ratio (%) | 1.52 | 1.29 | 1.72 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 7.83 |
| PBIT Margin (%) | 7.11 |
| PBT Margin (%) | -71.89 |
| Net PROFIT Margin (%) | 4.94 |
| Return On Networth / Equity (%) | 7.86 |
| Return On Networth /Employed (%) | 10.77 |
| Return On Assets (%) | 7.50 |
| Total Debt / Equity (X) | 0.05 |
| Asset Turnover Ratio (%) | 1.52 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 0.80 | 0.89 | 0.88 |
| Total Current Assets Annual | 9.66 | 10.18 | 10.05 |
| Non Current Assets Annual | 1.15 | 1.23 | 1.21 |
| Total Shareholders Funds Annual | 9.92 | 9.17 | 8.60 |
| Total Assets Annual | 10.81 | 11.41 | 11.25 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 0.80 |
| Total Current Assets Annual | 9.66 |
| Non Current Assets Annual | 1.15 |
| Total Shareholders Funds Annual | 9.92 |
| Total Assets Annual | 10.81 |
No Data Availabe
